Decision Diagnostics (OTC: DECN) “Game Changer” products for $25 billion diabetes monitoring market
Decision Diagnostics (OTC: DECN) CEO Keith Berman discusses the company’s products targeting the $25 billion global diabetes monitoring market, and the company’s path to achieving $100 […]
